At the 2016 American Society of Hematology (ASH) meeting, Dr. Brian Walker of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute joined Patient Power to discuss the importance of researching genes and mutations learn more about the intricacies of myeloma. Dr. Walker discusses how genetic sequencing plays a role in the use of targeted therapies and the development of new medications. He also speaks about the Myeloma Genome Project and how patients can be involved in this collaboration of research benefitting the future of medicine.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo